NCLT-convened shareholder meeting on Aug 17 for Adroit Biomed amalgamation
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
NCLT Mumbai has directed Alkem Laboratories to hold a court-convened meeting of equity shareholders on August 17, 2026 at 11 AM via video conferencing to consider the scheme of amalgamation of Adroit Biomed Limited (ABL), its wholly owned subsidiary, into the company. Since ABL is wholly owned, no new shares will be issued and existing shares of ABL will stand cancelled. Remote e-voting runs August 12-16, with cut-off date August 10. The scheme needs three-fourths in value approval from voting shareholders, followed by final NCLT sanction.
Procedural step in internal restructuring of a wholly owned subsidiary. No share dilution expected. Awaiting shareholder vote on Aug 17, 2026.